nach oben

Erschienen in:

01.12.2014 | Case Report

Malignant Dysphagia Treated by Esophageal Sparing Surgery with Good Prognosis

verfasst von: F. J. R. Teixeira Jr., A. V. Reis, R. S. S. Medeiros, E. H. Akaishi, V. C. Moutinho Jr., S. D. Couto Netto, T. M. Andrade Lima, A. L. F. Perina, F. O. Ferreira, G. O. Mendes, M. P. Lallé, E. M. Utiyama

Erschienen in: Journal of Gastrointestinal Cancer | Sonderheft 1/2014

Einloggen, um Zugang zu erhalten

Excerpt

Malignant dysphagia usually represents an ominous clinical symptom of upper digestive tract cancer. Esophageal carcinoma is the most common tumor causing malignant dysphagia [1‐3]. Radical surgery has a central role in the curative treatment usually in conjunction with chemo or radiation therapy [4‐6]. Despite advances in the field of multimodality treatment of the esophageal cancer, global long-term overall survival remains low [7]. …

Mason R. Palliation of oesophageal cancer. Surg Oncol. 2001;10:123–6.PubMedCrossRef

Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. 1993;104:510–3.PubMed

Brierley JD, Oza AM. Radiation and chemotherapy in the management of malignant esophageal strictures. Gastrointest Endosc Clin N Am. 1998;8:451–63.PubMed

Van Hagen P, Hulshof MC, van Lanschot JJ. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–84.PubMedCrossRef

Briez N, Piessen G, Bonnetain F, Brigand C. Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial—the MIRO trial. BMC Cancer. 2011;11(23):310.PubMedCentralPubMedCrossRef

Hulscher JB, van Sandick JW, de Boer AG. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347(21):1662–9.PubMedCrossRef

Rainer WG, Brus R. Leiomyosarcoma of the esophagus: review of the literatures and report of three cases. Surgery. 1965;58:343–50.PubMed

Mansour KA, Fritz RC, Jacobs DM. Pedunculated liposarcoma of the esophagus: a first case report. J Thorac Cardiovasc Surg. 1983;86:447–50.PubMed

Chitty EC. A case of esophageal polypus accompanied by a tumour of an accessory thyroid gland. Br J Surg. 1938;26:195–7.CrossRef

10.

Samson P, Zelman J. Pedunculated tumors of the esophagus. Arch Otolaryngol. 1942;36:203–11.CrossRef

11.

Weyrich G. Sudden death due to a pedunculated lipoma of the esophagus. Deutsche Zetschr fdgesgerichtl Med. 1933;21:164–7.

12.

Holt B. Fatty pendulous tumor of the pharynx and larynx. Trans Path Soc Lond. 1854;5:123–5.

13.

Penfold JB. Lipoma of the hypopharynx. Br Med J. 1952;1:1286.PubMedCentralPubMedCrossRef

14.

Allen MS, Talbot WH. Sudden death due to regurgitation of a pedunculated esophageal lipoma. J Thorac Cardiovasc Surg. 1967;54:756–8.PubMed

15.

Lejune F. Benign pedunculated esophageal tumors. Ann Otol Rhinol Laryngol. 1955;64:1261–9.CrossRef

16.

Cochet B, Hohl P, Sans M. Asphyxia caused by laryngeal tumor of an esophageal polyp. Arch Otolaryngol. 1980;106:176–8.PubMedCrossRef

17.

Caceres M, Steeb G, Wilks SM, Garret Jr HE. Large pedunculated polyps originating in the esophagus and hypopharynx. Ann Thorac Surg. 2006;81:393–6.PubMedCrossRef

18.

Will U, Lorenz P, Urban H. Curative endoscopic resection of a huge pedunculated esophageal liposarcoma. Endoscopy. 2007;39 Suppl 1:E15–6.PubMedCrossRef

19.

Chung JJ, Kim MJ, Kim JH. Imaging finds of giant liposarcoma of the esophagus. Yonsei Med J. 2003;44(4):715–8.PubMedCrossRef

20.

Torres-Mora J, AnnMoyer MT, Alexander J. Dedifferentiated liposarcoma arising in an esophageal polyp: a case report. Case reports in gastrointestinal medicine volume 2012, Article ID 141693, 3 pages.

21.

Aloraini A, Nahal A. Ferri LE transoral endoscopic resection of esophageal liposarcoma. Ann Thorac Surg. 2012;94(5):e121–2.PubMedCrossRef

22.

Taki K, Watanabe M, Iwagami S. Giant liposarcoma of the posterior mediastinum and retroperitoneum. BMJ Case Rep. 2011;11:2011.

23.

Sui X, Li Y, Wang J. Eur J Cardiothorac Surg. 2011;40(5):1253–5.PubMed

24.

Saleh WN, Aljehani YM, Ahmad MH. Giant pedunculated esophageal liposarcoma associated with Hurthle cell thyroid neoplasia. Saudi Med J. 2013;34(7):750–2.PubMed

25.

Yo I, Chung JW, Jeong MH. Huge liposarcoma of esophagus resected by endoscopic submucosal dissection: case report with video. Clin Endosc. 2013;46(3):297–300.PubMedCentralPubMedCrossRef

26.

Maruyama K, Motyama S, Okuyama M. Cervical approach for resection of a pedunculated giant atypical lipomatous tumor of the esophagus. Surg Today. 2007;37:173–5.PubMedCrossRef

27.

Xu S, Xu Z, Hou Y. Primary pedunculated giant esophageal liposarcoma: case report. Dysphagia. 2008;23:327–30.PubMedCrossRef

28.

Bin Y, Pei-zhi S, Xiao L. Well-differentiated liposarcoma of esophagus. Chin Med J. 2006;119(5):438–40.

29.

Liakakos TD, Troupis TG, Tzathas C. Primary liposarcoma of esophagus: a case report. World J Gastroenterol. 2006;12(7):1149–52.PubMedCentralPubMed

30.

Myung JK, Jeong JB, Han D. Well-differentiated liposarcoma of the oesophagus: clinicopathological, immunohistochemical and array CGH analysis. Pathol Oncol Res. 2011;17:415–20.PubMedCrossRef

31.

Crago AM, Singer S. Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma. Curr Opin Oncol. 2011;23:373–8.PubMedCentralPubMedCrossRef

32.

Muratani M, Tansey WP. How the ubiquitin-proteasome system controls transcription. Nat Rev Mol Cell Biol. 2003;4:192–201.PubMedCrossRef

33.

Smith MA, Kluck E, Jagannat S. Giant multi-polypoid liposarcoma of the esophagus: an atypical presentation. Ann Thorac Surg. 2010;89:610–2.PubMedCrossRef

34.

Kimura H, Dobaschi Y, Nojima T. Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics. Int J Clin Exp Pathol. 2013;6(7):1306–16.

35.

Smith MA, Kluck E, Jagannath S. Giant multi - polypoid liposarcoma of the Esophagus: an atypical presentation. Ann Thorac Surg. 2010;89:610–2.

Titel: Malignant Dysphagia Treated by Esophageal Sparing Surgery with Good Prognosis
verfasst von: F. J. R. Teixeira Jr.
A. V. Reis
R. S. S. Medeiros
E. H. Akaishi
V. C. Moutinho Jr.
S. D. Couto Netto
T. M. Andrade Lima
A. L. F. Perina
F. O. Ferreira
G. O. Mendes
M. P. Lallé
E. M. Utiyama
Publikationsdatum: 01.12.2014
Verlag: Springer US
Erschienen in: Journal of Gastrointestinal Cancer / Ausgabe Sonderheft 1/2014
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI: https://doi.org/10.1007/s12029-014-9645-4

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Springer Medizin

Malignant Dysphagia Treated by Esophageal Sparing Surgery with Good Prognosis

Excerpt

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

Sind Frauen die fähigeren Ärzte?

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 1/2014

Response to Nab-Paclitaxel plus Gemcitabine in a Patient with Primary Resistance to FOLFIRINOX

Lymphoepithelioma-Like Carcinoma of the Stomach with Incidental Gastrointestinal Stromal Tumor (GIST)—A Rare Synchrony of Two Tumors

Gastroduodenal Intussusception Secondary to a Pedunculated Brunner’s Gland Hamartoma: CT and Endoscopic Features

A Rare Case of Primary Pancreatic Hodgkin Lymphoma

Chronic Inflammation Predisposing to Cancer Metastasis: Lesson Learned from a Chronically Embedded Foreign Body in a Duodenal Diverticulum

Huge Pneumoretroperitoneum as the First Sign of Colorectal Cancer

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

Sind Frauen die fähigeren Ärzte?

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Onkologie